Guardian Pharmacy's 15-min chart shows KDJ Golden Cross and Bullish Marubozu pattern.

Guardian Pharmacy's 15-minute chart has recently triggered a KDJ Golden Cross, accompanied by a bullish Marubozu at 08/15/2025 13:30. This shift in momentum suggests that the stock price is poised to continue its upward trajectory, with potential for further growth. The control of buyers in the market reinforces the bullish sentiment, indicating that the momentum is likely to persist.

Guardian Pharmacy Services, Inc. (NYSE: GRDN) reported its financial results for the second quarter ended June 30, 2025, showcasing robust growth and a strong position in the long-term care ("LTC") pharmacy services sector. The company reported revenue of $344.3 million, up 15% year-over-year, driven by low double-digit organic growth and acquisitions completed over the past 12 months. The resident count ended the quarter at over 195,000, up 12% year-over-year [1].

Net income for the quarter was $8.8 million, a decrease from $15.8 million in the prior-year period, primarily due to income tax and share-based compensation expenses. Adjusted EBITDA, which excludes certain non-core expenses, was $25.0 million, compared to $21.7 million in the prior year. Diluted EPS was $0.14 for the quarter, with Adjusted EPS at $0.23 [1].

Guardian Pharmacy Services expanded its national presence during the quarter by adding two new pharmacies in Wichita, KS, and Seattle, WA, and launching a greenfield pharmacy in Naples, FL. Additionally, the company announced the acquisition of Managed Healthcare Pharmacy, establishing its first physical footprint in Oregon [1].

The company also completed a non-dilutive secondary offering of 8.625 million shares of Class A common stock, significantly increasing its public float and enhancing trading liquidity. This offering did not result in any change to the total number of Class A common stock outstanding [1].

Fred Burke, President and CEO of Guardian Pharmacy Services, commented, "We are proud to report another strong quarter for Guardian, with solid double-digit growth in revenue, resident count, and adjusted EBITDA. Our performance reflects disciplined execution by our local pharmacy teams, growing demand from our Assisted Living Facility (ALF) partners, and meaningful revenue contributions from thoughtful acquisitions." He further stated that the company is raising its full-year guidance across both revenue and adjusted EBITDA, reflecting better-than-expected organic growth and early contributions from the pharmacies added year-to-date [1].

The updated guidance for FY 2025 is as follows:
- Revenue: $1.39 billion - $1.41 billion (up from $1.33 billion - $1.35 billion)
- Adjusted EBITDA: $100.0 million - $102.0 million (up from $97.0 million - $101.0 million) [1]

Guardian Pharmacy Services is one of the nation's leading LTC pharmacy services companies, with a growing network of over 52 pharmacies nationwide, serving over 195,000 residents and approximately 7,400 LTCFs across 38 states [1].

The company's recent financial performance and strategic acquisitions position it as a strong leader in the ALF segment of LTC pharmacies, with a clear growth strategy and enhanced float from its secondary offering. Investors should closely monitor the company's future performance and the impact of its strategic initiatives on stock price movements [1].

References:
[1] https://www.stocktitan.net/news/GRDN/guardian-pharmacy-services-reports-second-quarter-2025-financial-c3em7a1ii61r.html